98%
921
2 minutes
20
Objective: To describe the application of data linkage for analysing coagulation abnormalities and blood transfusion practices in patients with chronic liver disease (CLD) presenting to emergency departments (EDs).
Methods: Patients with CLD presenting to 104 Queensland Health EDs (January 2016-August 2023) were identified using International Classification of Diseases codes. Phase 1 deterministically linked ED, admission, pathology, transfusion and death records using unique identifiers. Phase 2 used Structured Query Language (SQL) to capture transfusion timing. The model incorporated data from both digital and non-digitalised hospitals.
Results: Phase 1 linkage identified 36,643 ED presentations, 443,367 admissions, 47,357 deaths, 3,004,236 pathology results and 140,687 blood transfusion events. Phase 2 identified 23,578 ED presentations by 11,961 patients, linked to 20,312 admissions, 921 deaths, 22,284 full blood counts (FBC), 19,408 coagulation profiles, 3068 blood gases, 457 rotational thromboelastometry (ROTEM) and 53 thromboelastography tests. Transfusion data were linked to 1616 presentations, including of 1358 red blood cell (RBC) transfusion episodes, 330 fresh frozen plasma, 324 cryoprecipitate, 418 platelets, 51 fibrinogen concentrate and 280 Prothrombinex-VF administration episodes. High linkage rates were achieved for FBC (99.4%), coagulation profile (97.6%) and biochemistry (92.3%), while linkages for blood gas (34.6%), ROTEM (13.8%) and thromboelastography (2.5%) were less frequent. Massive transfusions occurred in 27 presentations (≥ 4 RBC units in 4 h) and in 22 presentations (≥ 10 RBC units in 24 h), with 100% linkage for FBC and coagulation profiles in both groups.
Conclusion: The feasibility of data linkage to investigate coagulation abnormalities and transfusion in CLD patients was demonstrated. This model provides a scalable method for haemovigilance and transfusion research.
Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12244256 | PMC |
http://dx.doi.org/10.1002/jha2.70101 | DOI Listing |
Alzheimers Dement
September 2025
Department of Population Health Sciences, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Introduction: We compared and measured alignment between the Health Level Seven (HL7) Fast Healthcare Interoperability Resources (FHIR) standard used by electronic health records (EHRs), the Clinical Data Interchange Standards Consortium (CDISC) standards used by industry, and the Uniform Data Set (UDS) used by the Alzheimer's Disease Research Centers (ADRCs).
Methods: The ADRC UDS, consisting of 5959 data elements across eleven packets, was mapped to FHIR and CDISC standards by two independent mappers, with discrepancies adjudicated by experts.
Results: Forty-five percent of the 5959 UDS data elements mapped to the FHIR standard, indicating possible electronic obtainment from EHRs.
Genome Biol
September 2025
Department of Clinical Pharmacy, Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA, 90089, USA.
Background: Recent advances in high-throughput sequencing technologies have enabled the collection and sharing of a massive amount of omics data, along with its associated metadata-descriptive information that contextualizes the data, including phenotypic traits and experimental design. Enhancing metadata availability is critical to ensure data reusability and reproducibility and to facilitate novel biomedical discoveries through effective data reuse. Yet, incomplete metadata accompanying public omics data may hinder reproducibility and reusability and limit secondary analyses.
View Article and Find Full Text PDFTheor Appl Genet
September 2025
Leibniz Institute of Plant Genetics and Crop Plant Research (IPK), Gatersleben, Germany.
The German Federal Ex Situ Genebank for Agricultural and Horticultural Crops (IPK) harbours over 3000 pea plant genetic resources (PGRs), backed up by corresponding information across 16 key agronomic and economical traits. The unbalanced structure and inconsistent format of this historical data has precluded effective leverage of genebank accessions, despite the opportunities contained in its genetic diversity. Therefore, a three-step statistical approach founded in linear mixed models was implemented to enable a rigorous and targeted data curation.
View Article and Find Full Text PDFBackground: The lncRNA-miRNA-mRNA regulatory network is recognized for its significant role in cardiovascular diseases, yet its involvement in in-stent restenosis (ISR) remains unexplored. Our study aimed to investigate how this regulatory network influences ISR occurrence and development by modulating inflammation and immunity.
Methods: By utilizing data extracted from the Gene Expression Omnibus (GEO) database, we constructed the lncRNA-miRNA-mRNA regulatory network specific to ISR.
Epidemiology
September 2025
Population Science, American Cancer Society, Atlanta, Georgia, US.
Background: Linking cancer cohort participants to state cancer registries typically relies on personally identifiable information, including Social Security Numbers (SSN), which uniquely identify individuals. However, complete SSN collection can be limited due to privacy concerns. This study evaluates the sensitivity of cancer registry linkage using partial or missing SSN and examines differences by demographic characteristics.
View Article and Find Full Text PDF